**BACKGROUNDS:** For locally advanced head and neck cancers, intra-arterial (IA) chemotherapy is utilized for locoregional control with favorable results. However, whether IA chemotherapy affects clinical outcome of microvascular reconstruction remains controversial.

**METHODS:** We retrospectively reviewed 572 patients who underwent head and neck microsurgical reconstruction from January 2014 to August 2018. Patients with prior history of chemotherapy were included and categorized into 2 groups according to history of IA chemotherapy (IA group)/intravenous (IV) chemotherapy (IV group). A 1:1 propensity score--matched analysis was performed. Microsurgical revision rates were evaluated along with complications and flap survival. Recipient vessel specimens were analyzed by histologic examination.

**RESULTS:** We identified 45 patients with IA chemotherapy and 201 patients with IV chemotherapy. The median time from chemotherapy to surgery was 2.3 months (0.6--51.2 months) in the IA group and 3.2 months (0.5--42.5 months) in the IV group. After propensity score matching, the IA group had significantly higher rates of arterial thrombosis (odds ratio \[OR\], 4.98; *P* = 0.021), wound-related complications (OR, 3.30; *P* = 0.02), and revision surgery within 1 month (OR, 3.73; *P* = 0.035). Based on histology, IA group vessels showed a higher intima/media ratio than the IV group (0.45 ± 0.06 versus 0.23 ± 0.03; *P* = 0.02).

**CONCLUSIONS:** Despite treating local advanced head and neck cancers with good results, IA chemotherapy may cause subsequent deleterious effects on local tissue due to the high concentration of cytotoxic chemotherapeutic agents. Surgeons should be cautious in selection of recipient vessels when performing microvascular reconstruction.
